OBI Pharma confirms FDA’s clearance of IND for Phase 1 Study of Monoclonal Antibody Cancer Immunotherapy Read more
MiMedx enrolls first patients in the Phase 3 IND Clinical Trial for treating Achilles Tendonitis Read more
APRINOIA Therapeutics finances US$11.1 Million Series B for developing imaging diagnostic and therapeutic pipelines Read more